French Pasteur Institute abandon Covid-19 vaccine development after phase 1 trials fail

France’s Pasteur Institute announced on Monday that it is ending the development of its Covid-19 vaccine after trial results proved disappointing. It appears that the vaccine failed to prove its efficacy in phase 1 trials. “The phase 1 of their trial that started in August. Although the vaccine was well tolerated by people, it seems like it didn’t spark sufficient immune system response”, FRANCE 24’s Julia Sieger reports.